These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6436303)

  • 1. Comparison of enzyme-linked immunosorbent and indirect hemagglutination assays for determining anthrax antibodies.
    Johnson-Winegar A
    J Clin Microbiol; 1984 Sep; 20(3):357-61. PubMed ID: 6436303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity.
    Turnbull PC; Broster MG; Carman JA; Manchee RJ; Melling J
    Infect Immun; 1986 May; 52(2):356-63. PubMed ID: 3084381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An enzyme-linked immunosorbent assay for detecting anthrax antibody in white-tailed deer (Odocoileus virginianus): evaluation of anthrax vaccination and sera from free-ranging deer.
    Peterson MJ; Davis DS; Templeton JW
    J Wildl Dis; 1993 Jan; 29(1):130-5. PubMed ID: 8445773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity.
    Turnbull PC; Leppla SH; Broster MG; Quinn CP; Melling J
    Med Microbiol Immunol; 1988; 177(5):293-303. PubMed ID: 3139974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a multiplexed fluorescent covalent microsphere immunoassay and an enzyme-linked immunosorbent assay for measurement of human immunoglobulin G antibodies to anthrax toxins.
    Biagini RE; Sammons DL; Smith JP; MacKenzie BA; Striley CA; Semenova V; Steward-Clark E; Stamey K; Freeman AE; Quinn CP; Snawder JE
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):50-5. PubMed ID: 14715544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization studies with attenuated strains of Bacillus anthracis.
    Ivins BE; Ezzell JW; Jemski J; Hedlund KW; Ristroph JD; Leppla SH
    Infect Immun; 1986 May; 52(2):454-8. PubMed ID: 3084383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme-linked immunosorbent assay using a recombinant baculovirus-expressed Bacillus anthracis protective antigen (PA): measurement of human anti-PA antibodies.
    Iacono-Connors LC; Novak J; Rossi C; Mangiafico J; Ksiazek T
    Clin Diagn Lab Immunol; 1994 Jan; 1(1):78-82. PubMed ID: 7496927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Search for correlates of protective immunity conferred by anthrax vaccine.
    Reuveny S; White MD; Adar YY; Kafri Y; Altboum Z; Gozes Y; Kobiler D; Shafferman A; Velan B
    Infect Immun; 2001 May; 69(5):2888-93. PubMed ID: 11292703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig.
    Little SF; Knudson GB
    Infect Immun; 1986 May; 52(2):509-12. PubMed ID: 3084385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-protective antigen IgG enzyme-linked immunosorbent assay for diagnosis of cutaneous anthrax in India.
    Ghosh N; Goel AK
    Clin Vaccine Immunol; 2012 Aug; 19(8):1238-42. PubMed ID: 22718130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of enzyme-linked immunosorbent assay and passive hemagglutination method for quantification of antibodies to lipopolysaccharide and tetanus toxoid in rats.
    Vos JG; Buys J; Hanstede JG; Hagenaars AM
    Infect Immun; 1979 Jun; 24(3):798-803. PubMed ID: 381201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of serologic tests for diagnosis of anthrax after an outbreak of cutaneous anthrax in Paraguay.
    Harrison LH; Ezzell JW; Abshire TG; Kidd S; Kaufmann AF
    J Infect Dis; 1989 Oct; 160(4):706-10. PubMed ID: 2507648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation and long term performance characteristics of a quantitative enzyme linked immunosorbent assay (ELISA) for human anti-PA IgG.
    Semenova VA; Schiffer J; Steward-Clark E; Soroka S; Schmidt DS; Brawner MM; Lyde F; Thompson R; Brown N; Foster L; Fox S; Patel N; Freeman AE; Quinn CP
    J Immunol Methods; 2012 Feb; 376(1-2):97-107. PubMed ID: 22197974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development & validation of a quantitative anti-protective antigen IgG enzyme linked immunosorbent assay for serodiagnosis of cutaneous anthrax.
    Ghosh N; Gunti D; Lukka H; Reddy BR; Padmaja J; Goel AK
    Indian J Med Res; 2015 Aug; 142(2):196-204. PubMed ID: 26354217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine.
    Grunow R; Porsch-Ozcürümez M; Splettstoesser W; Buckendahl A; Hahn U; Beyer W; Böhm R; Huber M; vd Esche U; Bessler W; Frangoulidis D; Finke EJ
    Vaccine; 2007 May; 25(18):3679-83. PubMed ID: 17287051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and application of a Bacillus anthracis protective antigen domain-1 in-house ELISA for the detection of anti-protective antigen antibodies in cattle in Zambia.
    Simbotwe M; Fujikura D; Ohnuma M; Omori R; Furuta Y; Muuka GM; Hang'ombe BM; Higashi H
    PLoS One; 2018; 13(10):e0205986. PubMed ID: 30335853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of protective anthrax antigen in agglutination reactions].
    Siromashkova M; Vylchev V; Avramova S; Mateev M
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Apr; (4):93-5. PubMed ID: 816124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of immunological adsorption in heterogeneous immunoenzyme analysis in determining antibodies to the protective determinants of Bacillus anthracis].
    Abalakin VA
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Nov; (11):90-4. PubMed ID: 2448978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunological properties of the preparations of the anti-anthrax antigen].
    Shliakhov EN; Gruz EV; Burdenko TA; Moroz LV
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Sep; (9):41-5. PubMed ID: 413294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin.
    Gaur R; Gupta PK; Banerjea AC; Singh Y
    Vaccine; 2002 Jun; 20(21-22):2836-9. PubMed ID: 12034111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.